The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity
Open Access
- 25 August 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (8) , e104986
Abstract
Due to the limited information of the contribution of various antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates, Antibiotic resistance mechanisms, including integron analysis, identification of quinolone resistance-determining region mutations, measurement of efflux pump activity, and sequence analysis of efflux pump regulators, were investigated in 66 clinical B. cepacia complex isolates. Species were identified via recA-RFLP and MALDI-TOF. Four genomovars were identified by recA-RFLP. B. cenocepacia (genomovar III) was the most prevalent genomovar (90.1%). Most isolates (60/66, 90.9%) were correctly identified by MALDI-TOF analysis. Clonal relatedness determined by PFGE analysis revealed 30 pulsotypes, including two major pulsotypes that comprised 22.7% and 18.2% of the isolates, respectively. Seventeen (25.8%) isolates harboured class 1 integron with various combinations of resistance genes. Among six levofloxacin-resistant isolates, five had single-base substitutions in the gyrA gene and three demonstrated efflux pump activities. Among the 42 isolates exhibiting resistance to at least one antimicrobial agent, 94.4% ceftazidime-resistant isolates (17/18) and 72.7% chloramphenicol-resistant isolates (16/22) demonstrated efflux pump activity. Quantitation of efflux pump RNA level and sequence analysis revealed that over-expression of the RND-3 efflux pump was attributable to specific mutations in the RND-3 efflux pump regulator gene. In conclusion, high-level expression of efflux pumps is prevalent in B. cepacia complex isolates. Mutations in the RND-3 efflux pump regulator gene are the major cause of efflux pump activity, resulting in the resistance to antibiotics in clinical B. cepacia complex isolates.Keywords
This publication has 37 references indexed in Scilit:
- Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteriaFEMS Microbiology Reviews, 2012
- Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia BiofilmsAntimicrobial Agents and Chemotherapy, 2011
- ampG Gene of Pseudomonas aeruginosa and Its Role in β-Lactamase ExpressionAntimicrobial Agents and Chemotherapy, 2010
- Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulenceClinical Microbiology and Infection, 2010
- Novel Insights about Class 2 Integrons from Experimental and Genomic EpidemiologyAntimicrobial Agents and Chemotherapy, 2010
- Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis PatientsAntimicrobial Agents and Chemotherapy, 2009
- The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis PatientsJournal of Bacteriology, 2009
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nonfermenting Gram-Negative Bacilli Isolated from Cystic Fibrosis PatientsJournal of Clinical Microbiology, 2008
- Fluoroquinolone-Resistant Mutants ofBurkholderia cepaciaAntimicrobial Agents and Chemotherapy, 2008
- The multifarious, multireplicon Burkholderia cepacia complexNature Reviews Microbiology, 2005